Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-04-19

AUTHORS

Massimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, Massimiliano Bonifacio, Domenica Gangemi, Federica Sorà, Alessandra Iurlo, Luigiana Luciano, Antonella Gozzini, Massimo Gentile, Monica Bocchia, Debora Luzi, Alessandro Maggi, Nicola Sgherza, Alessandro Isidori, Monica Crugnola, Patrizia Pregno, Anna Rita Scortechini, Isabella Capodanno, Michele Pizzuti, Robin Foà

ABSTRACT

Scarce information is available on the use of ponatinib as second-line treatment in chronic phase chronic myeloid leukemia (CP-CML) patients resistant and/or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. We collected data from 29 CML patients, with a median age of 54 years (range 32–72). Eleven patients had received dasatinib, 15 patients received nilotinib, and 3 patients received imatinib as first-line treatment. Forty-five percent of patients started ponatinib for secondary resistance, 38% for primary resistance, 7% for severe intolerance associated to a molecular warning, 7% due to the presence of a T315I mutation, and 3% for severe intolerance. Ponatinib was started at a dose of 45 mg in 60% of patients, 30 mg in 38%, and 15 mg in 2% of patients. Overall, at a median follow-up of 12 months, 85% of treated patients improved the level of response as compared to baseline, with 10 patients achieving a deep molecular response (MR4-4.5). No thrombotic events were recorded. The dose was reduced during treatment in 2 patients due to intolerance and in 8 patients in order to reduce the cardiovascular risk. Ponatinib seems a valid second-line treatment option for chronic phase CML, in particular for patients who failed a front-line second-generation TKI due to BCR-ABL-independent mechanisms of resistance. More... »

PAGES

1577-1580

Journal

TITLE

Annals of Hematology

ISSUE

9

VOLUME

97

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2

DOI

http://dx.doi.org/10.1007/s00277-018-3337-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103474297

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29675611


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Chronic-Phase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Patterns, Physicians'", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7841.a", 
          "name": [
            "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Breccia", 
        "givenName": "Massimo", 
        "id": "sg:person.01367650334.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367650334.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "S. Eugenio Hospital, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.416628.f", 
          "name": [
            "S. Eugenio Hospital, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abruzzese", 
        "givenName": "Elisabetta", 
        "id": "sg:person.0640660424.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640660424.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Hematology \u201cL. and A. Ser\u00e0gnoli,\u201d University Hospital, University of Bologna, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.6292.f", 
          "name": [
            "Institute of Hematology \u201cL. and A. Ser\u00e0gnoli,\u201d University Hospital, University of Bologna, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castagnetti", 
        "givenName": "Fausto", 
        "id": "sg:person.01326475234.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326475234.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Section of Hematology, University of Verona, Verona, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5611.3", 
          "name": [
            "Department of Medicine, Section of Hematology, University of Verona, Verona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonifacio", 
        "givenName": "Massimiliano", 
        "id": "sg:person.0611231355.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611231355.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fabrizio Spaziani Hospital, Frosinone, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Fabrizio Spaziani Hospital, Frosinone, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gangemi", 
        "givenName": "Domenica", 
        "id": "sg:person.0653234357.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653234357.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cattolica Sacro Cuore University, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.8142.f", 
          "name": [
            "Cattolica Sacro Cuore University, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sor\u00e0", 
        "givenName": "Federica", 
        "id": "sg:person.01171675501.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171675501.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, IRCCS Ca\u2019 Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Hematology Division, IRCCS Ca\u2019 Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iurlo", 
        "givenName": "Alessandra", 
        "id": "sg:person.0707634643.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707634643.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "\u2018Federico II\u2019 University of Naples, Naples, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4691.a", 
          "name": [
            "\u2018Federico II\u2019 University of Naples, Naples, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luciano", 
        "givenName": "Luigiana", 
        "id": "sg:person.013341024504.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013341024504.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AOU Careggi, University of Firenze, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.24704.35", 
          "name": [
            "AOU Careggi, University of Firenze, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gozzini", 
        "givenName": "Antonella", 
        "id": "sg:person.0774300321.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774300321.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Cosenza, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Cosenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gentile", 
        "givenName": "Massimo", 
        "id": "sg:person.0613701641.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613701641.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, University of Siena, Siena, Italy", 
          "id": "http://www.grid.ac/institutes/grid.9024.f", 
          "name": [
            "Hematology, University of Siena, Siena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bocchia", 
        "givenName": "Monica", 
        "id": "sg:person.01005160365.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005160365.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "S. Maria Hospital, Terni, Italy", 
          "id": "http://www.grid.ac/institutes/grid.416377.0", 
          "name": [
            "S. Maria Hospital, Terni, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luzi", 
        "givenName": "Debora", 
        "id": "sg:person.01050765065.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050765065.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Taranto, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Taranto, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maggi", 
        "givenName": "Alessandro", 
        "id": "sg:person.013666165762.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013666165762.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, \u2018Casa Sollievo della Sofferenza\u2019 Hospital, San Giovanni Rotondo, Italy", 
          "id": "http://www.grid.ac/institutes/grid.413503.0", 
          "name": [
            "Hematology, \u2018Casa Sollievo della Sofferenza\u2019 Hospital, San Giovanni Rotondo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sgherza", 
        "givenName": "Nicola", 
        "id": "sg:person.0705622142.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705622142.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Pesaro, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Pesaro, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isidori", 
        "givenName": "Alessandro", 
        "id": "sg:person.01017415177.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017415177.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Parma University, Parma, Italy", 
          "id": "http://www.grid.ac/institutes/grid.10383.39", 
          "name": [
            "Hematology, Parma University, Parma, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crugnola", 
        "givenName": "Monica", 
        "id": "sg:person.0731044026.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731044026.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza, Turin, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza, Turin, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pregno", 
        "givenName": "Patrizia", 
        "id": "sg:person.01047731772.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047731772.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Ancona, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Ancona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scortechini", 
        "givenName": "Anna Rita", 
        "id": "sg:person.01024360201.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024360201.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Capodanno", 
        "givenName": "Isabella", 
        "id": "sg:person.01123342467.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123342467.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ematologia, Potenza, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Ematologia, Potenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pizzuti", 
        "givenName": "Michele", 
        "id": "sg:person.0744016320.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744016320.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7841.a", 
          "name": [
            "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fo\u00e0", 
        "givenName": "Robin", 
        "id": "sg:person.0753276525.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753276525.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00277-016-2820-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041359361", 
          "https://doi.org/10.1007/s00277-016-2820-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-04-19", 
    "datePublishedReg": "2018-04-19", 
    "description": "Scarce information is available on the use of ponatinib as second-line treatment in chronic phase chronic myeloid leukemia (CP-CML) patients resistant and/or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. We collected data from 29 CML patients, with a median age of 54\u00a0years (range 32\u201372). Eleven patients had received dasatinib, 15 patients received nilotinib, and 3 patients received imatinib as first-line treatment. Forty-five percent of patients started ponatinib for secondary resistance, 38% for primary resistance, 7% for severe intolerance associated to a molecular warning, 7% due to the presence of a T315I mutation, and 3% for severe intolerance. Ponatinib was started at a dose of 45\u00a0mg in 60% of patients, 30\u00a0mg in 38%, and 15\u00a0mg in 2% of patients. Overall, at a median follow-up of 12\u00a0months, 85% of treated patients improved the level of response as compared to baseline, with 10 patients achieving a deep molecular response (MR4-4.5). No thrombotic events were recorded. The dose was reduced during treatment in 2 patients due to intolerance and in 8 patients in order to reduce the cardiovascular risk. Ponatinib seems a valid second-line treatment option for chronic phase CML, in particular for patients who failed a front-line second-generation TKI due to BCR-ABL-independent mechanisms of resistance.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-018-3337-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "97"
      }
    ], 
    "keywords": [
      "chronic phase chronic myeloid leukemia patients", 
      "second-line treatment", 
      "chronic myeloid leukemia patients", 
      "myeloid leukemia patients", 
      "severe intolerance", 
      "leukemia patients", 
      "prior tyrosine kinase inhibitor (TKI) therapy", 
      "second-line treatment option", 
      "first-line treatment", 
      "second-generation TKIs", 
      "tyrosine kinase inhibitor therapy", 
      "use of ponatinib", 
      "chronic phase CML", 
      "percent of patients", 
      "deep molecular response", 
      "kinase inhibitor therapy", 
      "real-life practice", 
      "BCR-ABL", 
      "cardiovascular risk", 
      "inhibitor therapy", 
      "median age", 
      "thrombotic events", 
      "treatment options", 
      "CML patients", 
      "primary resistance", 
      "secondary resistance", 
      "patients", 
      "T315I mutation", 
      "ponatinib", 
      "level of response", 
      "intolerance", 
      "treatment", 
      "independent mechanisms", 
      "dose", 
      "molecular response", 
      "scarce information", 
      "nilotinib", 
      "imatinib", 
      "TKIs", 
      "therapy", 
      "dasatinib", 
      "response", 
      "baseline", 
      "months", 
      "CML", 
      "age", 
      "risk", 
      "resistance", 
      "percent", 
      "options", 
      "years", 
      "mutations", 
      "levels", 
      "events", 
      "presence", 
      "mechanism", 
      "use", 
      "practice", 
      "data", 
      "information", 
      "warning", 
      "order", 
      "phase chronic myeloid leukemia (CP-CML) patients", 
      "molecular warning", 
      "valid second-line treatment option", 
      "phase CML", 
      "front-line second-generation TKI"
    ], 
    "name": "Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice", 
    "pagination": "1577-1580", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103474297"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-018-3337-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29675611"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-018-3337-2", 
      "https://app.dimensions.ai/details/publication/pub.1103474297"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_789.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-018-3337-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'


 

This table displays all metadata directly associated to this object as RDF triples.

379 TRIPLES      22 PREDICATES      108 URIs      99 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-018-3337-2 schema:about N097f5c9ef6ba4d73b77bd944db31aee5
2 N13d3fb423c3b4d45b42ea574d14d5d2a
3 N3dad0a0597104b1ba79b879ffac50612
4 N45eeb31bc9264035aaf1306530c270f6
5 N59ba64ada50d4bd19b91c67d2464930d
6 N5b574dfdf75e42fda753d49c7965cfef
7 N7bcb782120244b17bc6310a9d58e2af8
8 N83fbbd16b50742acb66d258a12520d19
9 Nbe6f94bc9e654960b53b0c9901fd1b41
10 Nc32fdc8336ec4ca6832811d770265351
11 Nc3b9755656234669b898d8307d0bd0f0
12 Ne060cbb2424b4e0a8cd9a266bfd7f79e
13 Ne3d2883ef40b4456941e4f1c7c504df8
14 Nfd28774364e34ff29527bf8c8a20dd7f
15 anzsrc-for:11
16 anzsrc-for:1102
17 schema:author Nab5ba8a3471d410c8d995486e4dc3bc1
18 schema:citation sg:pub.10.1007/s00277-016-2820-x
19 schema:datePublished 2018-04-19
20 schema:datePublishedReg 2018-04-19
21 schema:description Scarce information is available on the use of ponatinib as second-line treatment in chronic phase chronic myeloid leukemia (CP-CML) patients resistant and/or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. We collected data from 29 CML patients, with a median age of 54 years (range 32–72). Eleven patients had received dasatinib, 15 patients received nilotinib, and 3 patients received imatinib as first-line treatment. Forty-five percent of patients started ponatinib for secondary resistance, 38% for primary resistance, 7% for severe intolerance associated to a molecular warning, 7% due to the presence of a T315I mutation, and 3% for severe intolerance. Ponatinib was started at a dose of 45 mg in 60% of patients, 30 mg in 38%, and 15 mg in 2% of patients. Overall, at a median follow-up of 12 months, 85% of treated patients improved the level of response as compared to baseline, with 10 patients achieving a deep molecular response (MR4-4.5). No thrombotic events were recorded. The dose was reduced during treatment in 2 patients due to intolerance and in 8 patients in order to reduce the cardiovascular risk. Ponatinib seems a valid second-line treatment option for chronic phase CML, in particular for patients who failed a front-line second-generation TKI due to BCR-ABL-independent mechanisms of resistance.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N589f8b3dd9b24dbe8d5dc4686dcd1dc0
26 N8715cdbeeac84ab0b24e020fe3ea3a47
27 sg:journal.1358129
28 schema:keywords BCR-ABL
29 CML
30 CML patients
31 T315I mutation
32 TKIs
33 age
34 baseline
35 cardiovascular risk
36 chronic myeloid leukemia patients
37 chronic phase CML
38 chronic phase chronic myeloid leukemia patients
39 dasatinib
40 data
41 deep molecular response
42 dose
43 events
44 first-line treatment
45 front-line second-generation TKI
46 imatinib
47 independent mechanisms
48 information
49 inhibitor therapy
50 intolerance
51 kinase inhibitor therapy
52 leukemia patients
53 level of response
54 levels
55 mechanism
56 median age
57 molecular response
58 molecular warning
59 months
60 mutations
61 myeloid leukemia patients
62 nilotinib
63 options
64 order
65 patients
66 percent
67 percent of patients
68 phase CML
69 phase chronic myeloid leukemia (CP-CML) patients
70 ponatinib
71 practice
72 presence
73 primary resistance
74 prior tyrosine kinase inhibitor (TKI) therapy
75 real-life practice
76 resistance
77 response
78 risk
79 scarce information
80 second-generation TKIs
81 second-line treatment
82 second-line treatment option
83 secondary resistance
84 severe intolerance
85 therapy
86 thrombotic events
87 treatment
88 treatment options
89 tyrosine kinase inhibitor therapy
90 use
91 use of ponatinib
92 valid second-line treatment option
93 warning
94 years
95 schema:name Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
96 schema:pagination 1577-1580
97 schema:productId N03691fb0352a42e69b3ec26c8ef4efa5
98 N1450002ea935429387441df56b7b777b
99 Nc255c6c2bc1d4d778cc15b8e36e6e147
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103474297
101 https://doi.org/10.1007/s00277-018-3337-2
102 schema:sdDatePublished 2021-12-01T19:43
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher Ncbcb12d2656e4f9fb5d3810483a1b358
105 schema:url https://doi.org/10.1007/s00277-018-3337-2
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N023817096df843928f248c961da51c3c rdf:first sg:person.0653234357.40
110 rdf:rest Nda522f6ec3de4dd39c7456dddfd9af65
111 N0240e5c763f8465c86878e770dab69f4 rdf:first sg:person.01047731772.67
112 rdf:rest Nb2451cb71a444b2a90c9bba81c3d839b
113 N03691fb0352a42e69b3ec26c8ef4efa5 schema:name pubmed_id
114 schema:value 29675611
115 rdf:type schema:PropertyValue
116 N097f5c9ef6ba4d73b77bd944db31aee5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Practice Patterns, Physicians'
118 rdf:type schema:DefinedTerm
119 N09edafcb7178475a95e7f2aa84de5441 rdf:first sg:person.0640660424.09
120 rdf:rest Nfb1fa4c7baae4a46b23061c53181f9fe
121 N13d3fb423c3b4d45b42ea574d14d5d2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Male
123 rdf:type schema:DefinedTerm
124 N1450002ea935429387441df56b7b777b schema:name dimensions_id
125 schema:value pub.1103474297
126 rdf:type schema:PropertyValue
127 N1bd96de958db4bebb3f6e066f990ec6a rdf:first sg:person.01005160365.38
128 rdf:rest Nc251b822aa3f44bca377e6ce984e3618
129 N2f2952bbb653474385e9277a8d95abab rdf:first sg:person.013666165762.15
130 rdf:rest Nb1b1b489f9394ef28d4a91d1d3cdcdaf
131 N3dad0a0597104b1ba79b879ffac50612 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Leukemia, Myeloid, Chronic-Phase
133 rdf:type schema:DefinedTerm
134 N45eeb31bc9264035aaf1306530c270f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Aged
136 rdf:type schema:DefinedTerm
137 N4b837a87c80e4c268fc9d847779575f1 rdf:first sg:person.0774300321.37
138 rdf:rest N6b9bf8638c37402faf8a70a69ffbc0b4
139 N54328845b5dd4aad9b7ddcadd2d65042 rdf:first sg:person.013341024504.85
140 rdf:rest N4b837a87c80e4c268fc9d847779575f1
141 N589f8b3dd9b24dbe8d5dc4686dcd1dc0 schema:issueNumber 9
142 rdf:type schema:PublicationIssue
143 N59ba64ada50d4bd19b91c67d2464930d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Dose-Response Relationship, Drug
145 rdf:type schema:DefinedTerm
146 N5b574dfdf75e42fda753d49c7965cfef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Retrospective Studies
148 rdf:type schema:DefinedTerm
149 N6b9bf8638c37402faf8a70a69ffbc0b4 rdf:first sg:person.0613701641.42
150 rdf:rest N1bd96de958db4bebb3f6e066f990ec6a
151 N7960f6754df043b08936f7873282ca1c rdf:first sg:person.0611231355.00
152 rdf:rest N023817096df843928f248c961da51c3c
153 N7bcb782120244b17bc6310a9d58e2af8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Imidazoles
155 rdf:type schema:DefinedTerm
156 N83fbbd16b50742acb66d258a12520d19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 N8715cdbeeac84ab0b24e020fe3ea3a47 schema:volumeNumber 97
160 rdf:type schema:PublicationVolume
161 N8e2e2cb3e93e419f94d027e8f44565d3 rdf:first sg:person.0731044026.14
162 rdf:rest N0240e5c763f8465c86878e770dab69f4
163 N994347a45e334c2e803db8e17cb8ec2d rdf:first sg:person.01017415177.16
164 rdf:rest N8e2e2cb3e93e419f94d027e8f44565d3
165 Nab5ba8a3471d410c8d995486e4dc3bc1 rdf:first sg:person.01367650334.48
166 rdf:rest N09edafcb7178475a95e7f2aa84de5441
167 Nb1b1b489f9394ef28d4a91d1d3cdcdaf rdf:first sg:person.0705622142.10
168 rdf:rest N994347a45e334c2e803db8e17cb8ec2d
169 Nb2451cb71a444b2a90c9bba81c3d839b rdf:first sg:person.01024360201.11
170 rdf:rest Nd351cf162aaf4efc9512b34cd081886c
171 Nbe6f94bc9e654960b53b0c9901fd1b41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Female
173 rdf:type schema:DefinedTerm
174 Nc251b822aa3f44bca377e6ce984e3618 rdf:first sg:person.01050765065.93
175 rdf:rest N2f2952bbb653474385e9277a8d95abab
176 Nc255c6c2bc1d4d778cc15b8e36e6e147 schema:name doi
177 schema:value 10.1007/s00277-018-3337-2
178 rdf:type schema:PropertyValue
179 Nc32fdc8336ec4ca6832811d770265351 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Drug Resistance, Neoplasm
181 rdf:type schema:DefinedTerm
182 Nc3b9755656234669b898d8307d0bd0f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Chemotherapy, Adjuvant
184 rdf:type schema:DefinedTerm
185 Ncbcb12d2656e4f9fb5d3810483a1b358 schema:name Springer Nature - SN SciGraph project
186 rdf:type schema:Organization
187 Nd351cf162aaf4efc9512b34cd081886c rdf:first sg:person.01123342467.07
188 rdf:rest Nd5c8eba6d8084bcc95e3bcc00aed8f24
189 Nd5c8eba6d8084bcc95e3bcc00aed8f24 rdf:first sg:person.0744016320.63
190 rdf:rest Nf13e1786214e4431996b997d4551a181
191 Nda522f6ec3de4dd39c7456dddfd9af65 rdf:first sg:person.01171675501.11
192 rdf:rest Nf1f164dd17db4532b456cb98786fcd91
193 Ne060cbb2424b4e0a8cd9a266bfd7f79e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Adult
195 rdf:type schema:DefinedTerm
196 Ne3d2883ef40b4456941e4f1c7c504df8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Pyridazines
198 rdf:type schema:DefinedTerm
199 Nf13e1786214e4431996b997d4551a181 rdf:first sg:person.0753276525.11
200 rdf:rest rdf:nil
201 Nf1f164dd17db4532b456cb98786fcd91 rdf:first sg:person.0707634643.36
202 rdf:rest N54328845b5dd4aad9b7ddcadd2d65042
203 Nfb1fa4c7baae4a46b23061c53181f9fe rdf:first sg:person.01326475234.19
204 rdf:rest N7960f6754df043b08936f7873282ca1c
205 Nfd28774364e34ff29527bf8c8a20dd7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Humans
207 rdf:type schema:DefinedTerm
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
212 schema:name Cardiorespiratory Medicine and Haematology
213 rdf:type schema:DefinedTerm
214 sg:journal.1358129 schema:issn 0939-5555
215 1432-0584
216 schema:name Annals of Hematology
217 schema:publisher Springer Nature
218 rdf:type schema:Periodical
219 sg:person.01005160365.38 schema:affiliation grid-institutes:grid.9024.f
220 schema:familyName Bocchia
221 schema:givenName Monica
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005160365.38
223 rdf:type schema:Person
224 sg:person.01017415177.16 schema:affiliation grid-institutes:None
225 schema:familyName Isidori
226 schema:givenName Alessandro
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017415177.16
228 rdf:type schema:Person
229 sg:person.01024360201.11 schema:affiliation grid-institutes:None
230 schema:familyName Scortechini
231 schema:givenName Anna Rita
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024360201.11
233 rdf:type schema:Person
234 sg:person.01047731772.67 schema:affiliation grid-institutes:None
235 schema:familyName Pregno
236 schema:givenName Patrizia
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047731772.67
238 rdf:type schema:Person
239 sg:person.01050765065.93 schema:affiliation grid-institutes:grid.416377.0
240 schema:familyName Luzi
241 schema:givenName Debora
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050765065.93
243 rdf:type schema:Person
244 sg:person.01123342467.07 schema:affiliation grid-institutes:None
245 schema:familyName Capodanno
246 schema:givenName Isabella
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123342467.07
248 rdf:type schema:Person
249 sg:person.01171675501.11 schema:affiliation grid-institutes:grid.8142.f
250 schema:familyName Sorà
251 schema:givenName Federica
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171675501.11
253 rdf:type schema:Person
254 sg:person.01326475234.19 schema:affiliation grid-institutes:grid.6292.f
255 schema:familyName Castagnetti
256 schema:givenName Fausto
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326475234.19
258 rdf:type schema:Person
259 sg:person.013341024504.85 schema:affiliation grid-institutes:grid.4691.a
260 schema:familyName Luciano
261 schema:givenName Luigiana
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013341024504.85
263 rdf:type schema:Person
264 sg:person.013666165762.15 schema:affiliation grid-institutes:None
265 schema:familyName Maggi
266 schema:givenName Alessandro
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013666165762.15
268 rdf:type schema:Person
269 sg:person.01367650334.48 schema:affiliation grid-institutes:grid.7841.a
270 schema:familyName Breccia
271 schema:givenName Massimo
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367650334.48
273 rdf:type schema:Person
274 sg:person.0611231355.00 schema:affiliation grid-institutes:grid.5611.3
275 schema:familyName Bonifacio
276 schema:givenName Massimiliano
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611231355.00
278 rdf:type schema:Person
279 sg:person.0613701641.42 schema:affiliation grid-institutes:None
280 schema:familyName Gentile
281 schema:givenName Massimo
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613701641.42
283 rdf:type schema:Person
284 sg:person.0640660424.09 schema:affiliation grid-institutes:grid.416628.f
285 schema:familyName Abruzzese
286 schema:givenName Elisabetta
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640660424.09
288 rdf:type schema:Person
289 sg:person.0653234357.40 schema:affiliation grid-institutes:None
290 schema:familyName Gangemi
291 schema:givenName Domenica
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653234357.40
293 rdf:type schema:Person
294 sg:person.0705622142.10 schema:affiliation grid-institutes:grid.413503.0
295 schema:familyName Sgherza
296 schema:givenName Nicola
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705622142.10
298 rdf:type schema:Person
299 sg:person.0707634643.36 schema:affiliation grid-institutes:grid.4708.b
300 schema:familyName Iurlo
301 schema:givenName Alessandra
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707634643.36
303 rdf:type schema:Person
304 sg:person.0731044026.14 schema:affiliation grid-institutes:grid.10383.39
305 schema:familyName Crugnola
306 schema:givenName Monica
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731044026.14
308 rdf:type schema:Person
309 sg:person.0744016320.63 schema:affiliation grid-institutes:None
310 schema:familyName Pizzuti
311 schema:givenName Michele
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744016320.63
313 rdf:type schema:Person
314 sg:person.0753276525.11 schema:affiliation grid-institutes:grid.7841.a
315 schema:familyName Foà
316 schema:givenName Robin
317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753276525.11
318 rdf:type schema:Person
319 sg:person.0774300321.37 schema:affiliation grid-institutes:grid.24704.35
320 schema:familyName Gozzini
321 schema:givenName Antonella
322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774300321.37
323 rdf:type schema:Person
324 sg:pub.10.1007/s00277-016-2820-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041359361
325 https://doi.org/10.1007/s00277-016-2820-x
326 rdf:type schema:CreativeWork
327 grid-institutes:None schema:alternateName Ematologia, Potenza, Italy
328 Fabrizio Spaziani Hospital, Frosinone, Italy
329 Hematology, Ancona, Italy
330 Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy
331 Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
332 Hematology, Cosenza, Italy
333 Hematology, Pesaro, Italy
334 Hematology, Taranto, Italy
335 schema:name Ematologia, Potenza, Italy
336 Fabrizio Spaziani Hospital, Frosinone, Italy
337 Hematology, Ancona, Italy
338 Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy
339 Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
340 Hematology, Cosenza, Italy
341 Hematology, Pesaro, Italy
342 Hematology, Taranto, Italy
343 rdf:type schema:Organization
344 grid-institutes:grid.10383.39 schema:alternateName Hematology, Parma University, Parma, Italy
345 schema:name Hematology, Parma University, Parma, Italy
346 rdf:type schema:Organization
347 grid-institutes:grid.24704.35 schema:alternateName AOU Careggi, University of Firenze, Florence, Italy
348 schema:name AOU Careggi, University of Firenze, Florence, Italy
349 rdf:type schema:Organization
350 grid-institutes:grid.413503.0 schema:alternateName Hematology, ‘Casa Sollievo della Sofferenza’ Hospital, San Giovanni Rotondo, Italy
351 schema:name Hematology, ‘Casa Sollievo della Sofferenza’ Hospital, San Giovanni Rotondo, Italy
352 rdf:type schema:Organization
353 grid-institutes:grid.416377.0 schema:alternateName S. Maria Hospital, Terni, Italy
354 schema:name S. Maria Hospital, Terni, Italy
355 rdf:type schema:Organization
356 grid-institutes:grid.416628.f schema:alternateName S. Eugenio Hospital, Rome, Italy
357 schema:name S. Eugenio Hospital, Rome, Italy
358 rdf:type schema:Organization
359 grid-institutes:grid.4691.a schema:alternateName ‘Federico II’ University of Naples, Naples, Italy
360 schema:name ‘Federico II’ University of Naples, Naples, Italy
361 rdf:type schema:Organization
362 grid-institutes:grid.4708.b schema:alternateName Hematology Division, IRCCS Ca’ Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy
363 schema:name Hematology Division, IRCCS Ca’ Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy
364 rdf:type schema:Organization
365 grid-institutes:grid.5611.3 schema:alternateName Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
366 schema:name Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
367 rdf:type schema:Organization
368 grid-institutes:grid.6292.f schema:alternateName Institute of Hematology “L. and A. Seràgnoli,” University Hospital, University of Bologna, Bologna, Italy
369 schema:name Institute of Hematology “L. and A. Seràgnoli,” University Hospital, University of Bologna, Bologna, Italy
370 rdf:type schema:Organization
371 grid-institutes:grid.7841.a schema:alternateName Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University, Via Benevento 6, 00161, Rome, Italy
372 schema:name Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University, Via Benevento 6, 00161, Rome, Italy
373 rdf:type schema:Organization
374 grid-institutes:grid.8142.f schema:alternateName Cattolica Sacro Cuore University, Rome, Italy
375 schema:name Cattolica Sacro Cuore University, Rome, Italy
376 rdf:type schema:Organization
377 grid-institutes:grid.9024.f schema:alternateName Hematology, University of Siena, Siena, Italy
378 schema:name Hematology, University of Siena, Siena, Italy
379 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...